[Sporadic case of hemolytic uremic syndrome associated with verotoxin producing Escherichia coli O2:K1:H7]. 1993

Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
Department of Pediatrics, Ootawara Red Cross Hospital.

Cases of enterohaemorrhagic Escherichia coli (EHEC) are being increasingly reported in Japan. Bacteriological isolation of EHEC has been a constant problem because the organism is shed for a short duration after onset on illness and generally during the prodromal stages. In order to ease the diagnosis of EHEC infections in this country, we have developed a LPS-based solid phase enzyme linked immunosorbent assay for serological diagnosis of the infection. Adequate knowledge on the prevalence of EHEC serogroups in Japan is mandatory for the success of such a diagnostic test. O157 is currently the prominent serogroup associated with EHEC infections in Japan followed by O111, O26 and O128 in that order of prevalence. In February 1992, a 1 year-old infant developed hemolytic uremic syndrome (HUS) 15 days later the prodrome of watery diarrhoea. Stool sample obtained on day 15 was cultured for detection of EHEC. Ten colonies of E. coli picked from MacConkey agar plate were examined by the polymerase chain reaction (PCR) using primers specific for both verotoxins (VT1 and VT2). Of the 10 colonies, only one was positive for the VT2 gene. The strain was confirmed to be cytotoxic on cultured Vero cells. The strain agglutinated with antisera of E. coli O2, K1 and with H7 serogroups. As of date, none of such strains of O2:K1:H7 EHEC has been reported in Japan. The patient's sera was found to be positive for antibodies against LPS from the homologous isolate as well as against VT2. The patient recovered uneventfully from HUS 40 days after the onset of the disease and was discharged from the hospital.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D022622 Shiga Toxin 1 A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It is closely related to SHIGA TOXIN produced by SHIGELLA DYSENTERIAE. SLT-I,SLTI,Shiga-Like Toxin I,Stx1 Protein,VT1 Cytotoxin,Vero Cytotoxin VT1,Verocytotoxin 1,Verotoxin I,Protein, Stx1,SLT I,Shiga Like Toxin I

Related Publications

Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
July 1985, Canadian Medical Association journal,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
October 1988, Pediatric nephrology (Berlin, Germany),
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
September 1986, The Journal of infectious diseases,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
January 1995, Presse medicale (Paris, France : 1983),
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
March 1996, The Keio journal of medicine,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
March 1995, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
January 2005, Folia microbiologica,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
January 1999, Annales de biologie clinique,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
March 2000, Rinsho shinkeigaku = Clinical neurology,
Y Kobayashi, and K Maeyama, and Y Shiki, and T Tsukamoto, and T Nagai, and Y Peina, and H Nakao, and T Takeda
June 1998, Journal of clinical microbiology,
Copied contents to your clipboard!